Italia - italiano - Ministero della Salute

boehringer ingelheim animal health italia s.p.a - virus malattia di newcastle (pseudopeste aviarie), ceppo vg/ga-avinew, vivo - virus malattia di newcastle (pseudopeste aviarie); ceppo vg/ga-avinew; vivo - 5.5 log 10 eid 50 - dose infettante il 50% degli embrioni, virus vivo newcastle - 5.5 log 10 dose infettante il 50% degli embrioni, virus vivo newcastle - nd ; virus vivo newcastle - 5.5 log eid/50, virus vivo newcastle - 5.5 log eid/50; virus vivo newcastle - nd - newcastle disease virus / paramyxovirus

Italia - italiano - Ministero della Salute

boehringer ingelheim animal health italia s.p.a - virus vivo della pseudopeste ceppo vg/ga - virus vivo della pseudopeste ceppo vg/ga - 0 log/10 diu50 - newcastle disease virus / paramyxovirus

Unione Europea - italiano - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus antigeni di superficie (emoagglutinina e neuraminidasi) del ceppo a/vietnam/1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccini - immunizzazione attiva contro il sottotipo h5n1 del virus dell'influenza a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Unione Europea - italiano - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologici per aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Unione Europea - italiano - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologici per aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Unione Europea - italiano - EMA (European Medicines Agency)

intervet international b.v. - associati a cellule ricombinanti vivi turchia herpesvirus (ceppo hvp360), che esprimono la proteina di fusione di nd virus e la proteina vp2 di ibd virus - aviaria il virus dell'herpes (malattia di marek) + aviaria infettive bursal virus della malattia (malattia di gumboro) + virus della malattia di newcastle/paramyxovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Italia - italiano - Ministero della Salute

boehringer ingelheim animal health italia s.p.a - virus vivo attenuato (ceppo b1 type) della pseudopeste - virus vivo attenuato (ceppo b1 type) della pseudopeste - 10 elevato alla 6 die50/dose - newcastle disease virus / paramyxovirus

Unione Europea - italiano - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - virus delle cellule di tacchino ricombinante vivo-associato (rhvt / nd) che esprime la proteina di fusione del virus lentogeno d-26 del virus delle malattie di newcastle - prodotti immunologici per uccelli, live virali vaccini - chicken; embryonated eggs - per l'immunizzazione attiva dei 18 giorni di età embrionate di pollo, uova o pulcini di un giorno di ridurre la mortalità e segni clinici causati da virus della malattia di newcastle e di ridurre la mortalità, i segni clinici e le lesioni causate dal virus della malattia di marek con un fenotipo "virulento".

Unione Europea - italiano - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/california/7/2009 (h1n1)-derived strain used nymc x-181 - influenza, human; immunization; disease outbreaks - vaccini contro l'influenza - profilassi dell'influenza causata dal virus a (h1n1v) 2009. focetria dovrebbe essere usato in conformità con le linee guida ufficiali.

Unione Europea - italiano - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - pollo - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.